MAP2K6 anticorps (AA 1-334)

N° du produit ABIN7150721

Détail du produit anti-MAP2K6 anticorps

Antigène: MAP2K6 (Mitogen-Activated Protein Kinase Kinase 6 (MAP2K6))

Épitope: AA 1-334

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MAP2K6 est non-conjugé

Application: ELISA, Immunofluorescence (IF)

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Dual specificity mitogen-activated protein kinase kinase 6 protein (1-334AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IF:1:200-1:500,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur MAP2K6

Antigène: MAP2K6 (Mitogen-Activated Protein Kinase Kinase 6 (MAP2K6))

Autre désignation: MAP2K6 (MAP2K6 Produits)

Synonymes: anticorps MAPKK6, anticorps MEK6, anticorps MKK6, anticorps PRKMK6, anticorps SAPKK-3, anticorps SAPKK3, anticorps Mkk6, anticorps Prkmk6, anticorps MKK3, anticorps map2k3, anticorps zMKK3, anticorps map2k6, anticorps mitogen-activated protein kinase kinase 6, anticorps mitogen-activated protein kinase kinase 6 L homeolog, anticorps MAP2K6, anticorps Map2k6, anticorps map2k6, anticorps map2k6.L

Sujet:

Background: Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. With MAP3K3/MKK3, catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in the MAP kinases p38 MAPK11, MAPK12, MAPK13 and MAPK14 and plays an important role in the regulation of cellular responses to cytokines and all kinds of stresses. Especially, MAP2K3/MKK3 and MAP2K6/MKK6 are both essential for the activation of MAPK11 and MAPK13 induced by environmental stress, whereas MAP2K6/MKK6 is the major MAPK11 activator in response to TNF. MAP2K6/MKK6 also phosphorylates and activates PAK6. The p38 MAP kinase signal transduction pathway leads to direct activation of transcription factors. Nuclear targets of p38 MAP kinase include the transcription factors ATF2 and ELK1. Within the p38 MAPK signal transduction pathway, MAP3K6/MKK6 mediates phosphorylation of STAT4 through MAPK14 activation, and is therefore required for STAT4 activation and STAT4-regulated gene expression in response to IL-12 stimulation. The pathway is also crucial for IL-6-induced SOCS3 expression and down-regulation of IL-6-mediated gene induction, and for IFNG-dependent gene transcription. Has a role in osteoclast differentiation through NF-kappa-B transactivation by TNFSF11, and in endochondral ossification and since SOX9 is another likely downstream target of the p38 MAPK pathway. MAP2K6/MKK6 mediates apoptotic cell death in thymocytes. Acts also as a regulator for melanocytes dendricity, through the modulation of Rho family GTPases.

Aliases: Dual specificity mitogen activated protein kinase kinase 6 antibody, Dual specificity mitogen-activated protein kinase kinase 6 antibody, MAP kinase kinase 6 antibody, MAP2K6 antibody, MAPK/ERK kinase 6 antibody, MAPKK 6 antibody, MAPKK6 antibody, MEK 6 antibody, MEK6 antibody, Mitogen Activated Protein Kinase Kinase 6 antibody, MKK 6 antibody, MKK6 antibody, MP2K6_HUMAN antibody, PRKMK6 antibody, protein kinase antibody, Protein kinase mitogen activated kinase 6 antibody, protein kinase, mitogen-activated, kinase 6 (MAP kinase kinase 6) antibody, SAPK kinase 3 antibody, SAPKK-3 antibody, SAPKK3 antibody, SKK3 antibody, Stress-activated protein kinase kinase 3 antibody

UniProt: P52564

Pathways: Signalisation MAPK, Signalisation TLR, Activation of Innate immune Response, Regulation of Muscle Cell Differentiation, Toll-Like Receptors Cascades